← FDA Drug Approvals (Drugs@FDA)

DIAZEPAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2014-04-14

Drug application

FDA Application #

ANDA204433

Application type

Abbreviated New Drug Application (Generic)

Brand name

DIAZEPAM

Generic name

DIAZEPAM ORAL SOLUTION (CONCENTRATE)

Active ingredients

DIAZEPAM

Dosage form

CONCENTRATE

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell RX, LLC

First approval

2014-04-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown